• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

    7/20/26 5:42:00 PM ET
    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Industrial Specialties
    Health Care
    Get the next $KRYS alert in real time by email

    NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: 

    • S&P SmallCap 600 constituent Krystal Biotech Inc. (NASD: KRYS) will replace Taylor Morrison Home Corp. (NYSE:TMHC) in the S&P MidCap 400, and Tutor Perini Corp. (NYSE:TPC) will replace Krystal Biotech in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 24. S&P 500 & 100 constituent Berkshire Hathaway Inc. (NYSE:BRK) is acquiring Taylor Morrison Home in a deal expected to close on or about that date, pending final closing conditions.

        
    • V2X Inc. (NYSE: VVX) will replace Avanos Medical Inc. (NYSE:AVNS) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, July 27. American Industrial Partners is acquiring Avanos Medical in a deal expected to close soon, pending final closing conditions.

    Following is a summary of the changes that will take place prior to the open of trading on the effective date:

    Effective Date

    Index Name

    Action

    Company Name

    Ticker

    GICS Sector

    July 24, 2026

    S&P MidCap 400

    Addition

    Krystal Biotech

    KRYS

    Health Care

    July 24, 2026

    S&P MidCap 400

    Deletion

    Taylor Morrison Home

    TMHC

    Consumer Discretionary

    July 24, 2026

    S&P SmallCap 600

    Addition

    Tutor Perini Corp

    TPC

    Industrials

    July 24, 2026

    S&P SmallCap 600

    Deletion

    Krystal Biotech

    KRYS

    Health Care

    July 27, 2026

    S&P SmallCap 600

    Addition

    V2X

    VVX

    Industrials

    July 27, 2026

    S&P SmallCap 600

    Deletion

    Avanos Medical

    AVNS

    Health Care

    ABOUT S&P DOW JONES INDICES

    S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

    S&P Dow Jones Indices is a division of S&P Global (NYSE:SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spglobal.com/spdji/en/. 

    FOR MORE INFORMATION:

    S&P Dow Jones Indices

    index_services@spglobal.com

    Media Inquiries

    spdji.comms@spglobal.com

    Cision View original content:https://www.prnewswire.com/news-releases/krystal-biotech-set-to-join-sp-midcap-400-tutor-perini-and-v2x-to-join-sp-smallcap-600-302830022.html

    SOURCE S&P Dow Jones Indices

    Get the next $KRYS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KRYS
    $AVNS
    $BRK.A
    $BRK.B

    CompanyDatePrice TargetRatingAnalyst
    Taylor Morrison Home Corporation
    $TMHC
    7/14/2026$73.00Overweight → Equal Weight
    Barclays
    V2X Inc.
    $VVX
    6/24/2026Outperform → Mkt Perform
    Raymond James
    V2X Inc.
    $VVX
    4/16/2026$74.00Equal-Weight
    Morgan Stanley
    Taylor Morrison Home Corporation
    $TMHC
    4/7/2026$49.00Buy → Sell
    Seaport Research Partners
    Krystal Biotech Inc.
    $KRYS
    3/27/2026Peer Perform
    Wolfe Research
    Taylor Morrison Home Corporation
    $TMHC
    3/4/2026$85.00Buy
    Truist
    S&P Global Inc.
    $SPGI
    2/17/2026$575.00Buy
    BofA Securities
    Taylor Morrison Home Corporation
    $TMHC
    1/16/2026$70.00Buy → Neutral
    BofA Securities
    More analyst ratings

    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by Berkshire Hathaway Inc.

    SCHEDULE 13D/A - BERKSHIRE HATHAWAY INC (0001067983) (Subject)

    7/15/26 4:30:26 PM ET
    $BRK.B

    SEC Form DEFA14A filed by Avanos Medical Inc.

    DEFA14A - AVANOS MEDICAL, INC. (0001606498) (Filer)

    7/14/26 7:18:46 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    Avanos Medical Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)

    7/14/26 7:18:06 PM ET
    $AVNS
    Industrial Specialties
    Health Care

    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Taylor Morrison Home downgraded by Barclays with a new price target

    Barclays downgraded Taylor Morrison Home from Overweight to Equal Weight and set a new price target of $73.00

    7/14/26 9:02:56 AM ET
    $TMHC
    Homebuilding
    Consumer Discretionary

    V2X downgraded by Raymond James

    Raymond James downgraded V2X from Outperform to Mkt Perform

    6/24/26 8:39:23 AM ET
    $VVX
    Diversified Commercial Services
    Consumer Discretionary

    Morgan Stanley resumed coverage on V2X with a new price target

    Morgan Stanley resumed coverage of V2X with a rating of Equal-Weight and set a new price target of $74.00

    4/16/26 7:54:24 AM ET
    $VVX
    Diversified Commercial Services
    Consumer Discretionary

    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

    NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600:  S&P SmallCap 600 constituent Krystal Biotech Inc. (NASD: KRYS) will replace Taylor Morrison Home Corp. (NYSE:TMHC) in the S&P MidCap 400, and Tutor Perini Corp. (NYSE:TPC) will replace Krystal Biotech in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 24. S&P 500 & 100 constituent Berkshire Hathaway Inc. (NYSE:BRK) is acquiring Taylor Morrison Home in a deal expected to close on or about that date, pending final closing conditions.  V2X Inc. (NYSE: VVX) will replace Avanos Medical Inc. (NYSE:AVNS) in the S&P SmallCap 600 effect

    7/20/26 5:42:00 PM ET
    $KRYS
    $AVNS
    $BRK.A
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Industrial Specialties
    Finance: Consumer Services

    S&P DOW JONES INDICES AND MSCI ANNOUNCE CONSULTATION ON POTENTIAL CHANGES TO THE GLOBAL INDUSTRY CLASSIFICATION STANDARD (GICS®)

    NEW YORK, July 17, 2026 /PRNewswire/ -- S&P Dow Jones Indices (S&P DJI), a leading provider of financial market indices, and MSCI Inc. (MSCI), a leading provider of critical decision support tools and services have decided to consult with members of the investment community on potential changes to the GICS structure. The review is intended to ensure that the GICS structure is reflective of today's markets and continues to be an accurate and complete industry framework. The consultation begins on July 17, 2026, and ends on October 30, 2026. Any changes to the GICS structure will be announced by November 2026. This consultation may or may not result in any changes to the GICS structure.Key top

    7/17/26 6:03:00 PM ET
    $MSCI
    $SPGI
    Real Estate
    Finance: Consumer Services
    Finance

    Molina Healthcare Set to Join S&P MidCap 400 and Construction Partners to Join S&P SmallCap 600

    NEW YORK, July 16, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent Molina Healthcare Inc. (NYSE: MOH) will replace National Storage Affiliates Trust (NYSE:NSA) in the S&P MidCap 400, and Construction Partners Inc. (NASD: ROAD) will replace Molina Healthcare in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 22. S&P 500 constituent Public Storage (NYSE:PSA) is acquiring National Storage Affiliates Trust in a deal that is expected to be completed on or about that date pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGI

    7/16/26 5:56:00 PM ET
    $ROAD
    $MOH
    $NSA
    Military/Government/Technical
    Industrials
    Medical Specialities
    Health Care

    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Buffett Warren E converted options into 12,000,000 units of Class B Common Stock and gifted 12,000,000 units of Class B Common Stock (SEC Form 4)

    4 - BERKSHIRE HATHAWAY INC (0001067983) (Issuer)

    7/15/26 4:32:25 PM ET
    $BRK.B

    New insider Thomas Darren Robert claimed ownership of 6,174 shares (SEC Form 3)

    3 - S&P Global Inc. (0000064040) (Issuer)

    7/9/26 4:05:00 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by President, S&P Global Mobility Eager William W

    4 - S&P Global Inc. (0000064040) (Issuer)

    7/6/26 5:25:04 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer O'Sullivan Michael J. bought $250,545 worth of Class B Common Stock (536 units at $467.44) (SEC Form 4)

    4 - BERKSHIRE HATHAWAY INC (0001067983) (Issuer)

    5/6/26 7:04:10 PM ET
    $BRK.B

    Director Moritz Robert Edward Jr. bought $500,001 worth of shares (1,152 units at $434.03) (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    5/4/26 4:19:22 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    CEO, S&P Dow Jones Indices Clay Catherine R bought $1,078,475 worth of shares (2,500 units at $431.39) (SEC Form 4)

    4 - S&P Global Inc. (0000064040) (Issuer)

    5/4/26 4:18:28 PM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    May 19, 2023 - FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa

    For Immediate Release: May 19, 2023 Today, the U.S. Food and Drug Administration approved Vyjuvek, a herpes-simplex virus type 1 (HSV-1) vector-based gene therapy, for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.  “Vyjuvek is the first FDA-approved gene therapy treatment for DEB, a

    5/19/23 1:48:20 PM ET
    $KRYS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    Financials

    Live finance-specific insights

    View All

    V2X to Announce Second Quarter 2026 Financial Results

    RESTON, Va., July 14, 2026 /PRNewswire/ -- V2X, Inc., (NYSE:VVX), a leading provider of global mission solutions, will report second quarter 2026 financial results on Monday, August 3, 2026, after market close. Senior management will conduct a conference call at 4:30 p.m. ET that same day. U.S.-based participants may dial in to the conference call at 877-300-8521, while international participants may dial 412-317-6026. A live webcast of the conference call as well as an accompanying slide presentation will be available at https://app.webinar.net/9LeOmbNmDjb and on the Investors section of the V2X website at https://gov2x.com/.A

    7/14/26 7:27:00 AM ET
    $VVX
    Diversified Commercial Services
    Consumer Discretionary

    S&P Global Evolves Market Intelligence Operating Model to Accelerate Agentic Solutions, Platform Capabilities and Innovation; Announces Executive Leadership Changes

    NEW YORK, July 6, 2026 /PRNewswire/ -- S&P Global (NYSE:SPGI) today announced the new Market Intelligence operating model. This evolution is designed to better align the business with changing customer needs and to position the company for growth in an AI-driven market, pairing its unmatched breadth and depth of data and deep domain expertise with more integrated AI-powered tools, workflows and experiences. S&P Global Market Intelligence will be organized into two focused verticals with distinct but complementary areas, Kensho Data & Platforms and Enterprise Solutions, enabling a streamlined and unified approach to help custome

    7/6/26 7:48:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    S&P Global Schedules Second Quarter 2026 Earnings Announcement and Conference Call for Tuesday, July 28, 2026

    NEW YORK, July 6, 2026 /PRNewswire/ -- S&P Global's (NYSE:SPGI) second quarter 2026 results will be issued on Tuesday, July 28, 2026 via news release at approximately 7:15 a.m. Eastern Daylight Time. The news release will be available at www.spglobal.com. Martina Cheung, President and CEO; Eric Aboaf, Chief Financial Officer; and Mark Grant, Senior Vice President, Investor Relations and Treasurer, will host a conference call and webcast at 8:30 a.m. Eastern Daylight Time on July 28, 2026 to discuss the Company's second quarter 2026 financial results.The presentation is open to all interested parties and may include forward-look

    7/6/26 7:48:00 AM ET
    $SPGI
    Finance: Consumer Services
    Finance

    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    Leadership Updates

    Live Leadership Updates

    View All

    Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

    NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600:  S&P SmallCap 600 constituent Krystal Biotech Inc. (NASD: KRYS) will replace Taylor Morrison Home Corp. (NYSE:TMHC) in the S&P MidCap 400, and Tutor Perini Corp. (NYSE:TPC) will replace Krystal Biotech in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 24. S&P 500 & 100 constituent Berkshire Hathaway Inc. (NYSE:BRK) is acquiring Taylor Morrison Home in a deal expected to close on or about that date, pending final closing conditions.  V2X Inc. (NYSE: VVX) will replace Avanos Medical Inc. (NYSE:AVNS) in the S&P SmallCap 600 effect

    7/20/26 5:42:00 PM ET
    $KRYS
    $AVNS
    $BRK.A
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Industrial Specialties
    Finance: Consumer Services

    Molina Healthcare Set to Join S&P MidCap 400 and Construction Partners to Join S&P SmallCap 600

    NEW YORK, July 16, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent Molina Healthcare Inc. (NYSE: MOH) will replace National Storage Affiliates Trust (NYSE:NSA) in the S&P MidCap 400, and Construction Partners Inc. (NASD: ROAD) will replace Molina Healthcare in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 22. S&P 500 constituent Public Storage (NYSE:PSA) is acquiring National Storage Affiliates Trust in a deal that is expected to be completed on or about that date pending final conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name       ActionCompany NameTickerGI

    7/16/26 5:56:00 PM ET
    $ROAD
    $MOH
    $NSA
    Military/Government/Technical
    Industrials
    Medical Specialities
    Health Care

    BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600

    NEW YORK, July 14, 2026 /PRNewswire/ -- S&P SmallCap 600 constituent BrightSpring Health Services Inc. (NASD: BTSG) will replace Chart Industries Inc. (NYSE:GTLS) in the S&P MidCap 400, and Karman Holdings Inc. (NYSE:KRMN) will replace BrightSpring Health Services in the S&P SmallCap 600 effective prior to the opening of trading on Friday, July 17. S&P 500 constituent Baker Hughes Co. (NASD: BKR) is to acquire Chart Industries in a deal expected to close July 16, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date:Effective DateIndex Name ActionCompany NameTickerGICS SectorJuly 17, 2026S&P MidCap 400A

    7/14/26 5:54:00 PM ET
    $BKR
    $BTSG
    $GTLS
    Oil and Gas Field Machinery
    Consumer Discretionary
    Medical/Nursing Services
    Health Care

    $KRYS
    $AVNS
    $BRK.A
    $BRK.B
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Berkshire Hathaway Inc.

    SC 13D/A - BERKSHIRE HATHAWAY INC (0001067983) (Subject)

    11/25/24 3:09:49 PM ET
    $BRK.B

    Amendment: SEC Form SC 13D/A filed by V2X Inc.

    SC 13D/A - V2X, Inc. (0001601548) (Subject)

    11/18/24 4:05:27 PM ET
    $VVX
    Diversified Commercial Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Krystal Biotech Inc.

    SC 13G/A - Krystal Biotech, Inc. (0001711279) (Subject)

    11/14/24 9:00:58 PM ET
    $KRYS
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care